Galectin-1 inhibitors and their potential therapeutic applications: a patent review
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-1 inhibitors and their potential therapeutic applications: a patent review
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 26, Issue 5, Pages 537-554
Publisher
Informa Healthcare
Online
2016-03-08
DOI
10.1517/13543776.2016.1163338
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin expression in cancer diagnosis and prognosis: A systematic review
- (2015) Victor L. Thijssen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Redox state influence on human galectin-1 function
- (2015) Xing Yu et al. BIOCHIMIE
- Liposome-based Formulation for Intracellular Delivery of Functional Proteins
- (2015) Benoît Chatin et al. Molecular Therapy-Nucleic Acids
- Galectin-1-secreting neural stem cells elicit long-term neuroprotection against ischemic brain injury
- (2015) Jiayin Wang et al. Scientific Reports
- Synthetic Galectin-3 Inhibitor Increases Metastatic Cancer Cell Sensitivity to Taxol-Induced Apoptosis In Vitro and In Vivo
- (2015) Vladislav V. Glinsky et al. NEOPLASIA
- Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine
- (2015) Olga V. Glinskii et al. NEOPLASIA
- Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics
- (2014) Helen Blanchard et al. AUSTRALIAN JOURNAL OF CHEMISTRY
- Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists
- (2014) Vishal Kumar Rajput et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Recent advances in characterization of nonviral vectors for delivery of nucleic acids: impact on their biological performance
- (2014) Claudia Oliveira et al. Expert Opinion on Drug Delivery
- Galectin-3 inhibitors: a patent review (2008–present)
- (2014) Helen Blanchard et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Galectin-1 and -9 in angiogenesis: A sweet couple
- (2014) V. L. Thijssen et al. GLYCOBIOLOGY
- Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment
- (2014) D. O. Croci et al. GLYCOBIOLOGY
- Structural basis of redox-dependent modulation of galectin-1 dynamics and function
- (2014) Carlos M Guardia et al. GLYCOBIOLOGY
- Differential Roles of Galectin-1 and Galectin-3 in Regulating Leukocyte Viability and Cytokine Secretion
- (2014) S. R. Stowell et al. JOURNAL OF IMMUNOLOGY
- Mammalian galectins bind Galactoseβ1–4Fucose disaccharide, a unique structural component of protostomial N-type glycoproteins
- (2013) Tomoharu Takeuchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib
- (2013) Massimo Zucchetti et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Unraveling galectin-1 as a novel therapeutic target for cancer
- (2013) Lucile Astorgues-Xerri et al. CANCER TREATMENT REVIEWS
- Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target
- (2013) Karel Smetana et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer
- (2013) Ruud P. M. Dings et al. INVESTIGATIONAL NEW DRUGS
- Tuning the Preference of Thiodigalactoside- and Lactosamine-Based Ligands to Galectin-3 over Galectin-1
- (2013) Hilde van Hattum et al. JOURNAL OF MEDICINAL CHEMISTRY
- Single-Site Mutational Engineering and Following MonoPEGylation of the Human Lectin Galectin-2: Effects on Ligand Binding, Functional Aspects, and Clearance from Serum
- (2013) Jürgen Kopitz et al. MOLECULAR PHARMACEUTICS
- Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma
- (2013) María L Bacigalupo WORLD JOURNAL OF GASTROENTEROLOGY
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Targeting Galectin-1 Overcomes Breast Cancer-Associated Immunosuppression and Prevents Metastatic Disease
- (2012) T. Dalotto-Moreno et al. CANCER RESEARCH
- Synthesis of lactosylated glycoclusters and inhibition studies with plant and human lectins
- (2012) Samy Cecioni et al. CARBOHYDRATE RESEARCH
- Glycobiology in Malignant Gliomas: Expression and Functions of Galectins and Possible Therapeutic Options
- (2012) Herwig M. Strik et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Neural stem cells, adult neurogenesis, and galectin-1: From bench to bedside
- (2012) Masanori Sakaguchi et al. Developmental Neurobiology
- High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion
- (2012) Ha-Jeong Kim et al. EUROPEAN JOURNAL OF CANCER
- Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer
- (2012) Ha-Jeong Kim et al. HUMAN PATHOLOGY
- Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding
- (2012) Ruud P. M. Dings et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bi- to tetravalent glycoclusters: synthesis, structure–activity profiles as lectin inhibitors and impact of combining both valency and headgroup tailoring on selectivity
- (2012) Guan-Nan Wang et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent
- (2012) Ju Bo Wang et al. PEPTIDES
- The sweet and bitter sides of galectins in melanoma progression
- (2012) Russell R. Braeuer et al. Pigment Cell & Melanoma Research
- A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis
- (2012) D Xibillé-Friedmann et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Galectin-1-Specific Inhibitors as a New Class of Compounds To Treat HIV-1 Infection
- (2011) Christian St-Pierre et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibitory potential of chemical substitutions at bioinspired sites of β-d-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins
- (2011) Denis Giguère et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Taloside Inhibitors of Galectin-1 and Galectin-3
- (2011) Patrick M. Collins et al. Chemical Biology & Drug Design
- Arene-Anion Based Arginine-Binding Motif on a Galactose Scaffold: Structure-Activity Relationships of Interactions with Arginine-Rich Galectins
- (2011) Christopher T. Öberg et al. CHEMISTRY-A EUROPEAN JOURNAL
- Galectin-1 research in T cell immunity: Past, present and future
- (2011) Filiberto Cedeno-Laurent et al. CLINICAL IMMUNOLOGY
- Galectin-1 and immunotherapy for brain cancer
- (2011) Tina Verschuere et al. Expert Review of Neurotherapeutics
- The role of galectins in colorectal cancer progression
- (2011) Hannah Barrow et al. INTERNATIONAL JOURNAL OF CANCER
- The Anti-angiogenic Peptide Anginex Greatly Enhances Galectin-1 Binding Affinity for Glycoproteins
- (2011) Emma Salomonsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Host-Soluble Galectin-1 Promotes HIV-1 Replication through a Direct Interaction with Glycans of Viral gp120 and Host CD4
- (2011) C. St-Pierre et al. JOURNAL OF VIROLOGY
- Synthesis of 3-amido-3-deoxy-β-d-talopyranosides: all-cis-substituted pyranosides as lectin inhibitors
- (2011) Christopher T. Öberg et al. TETRAHEDRON
- Monovalent Interactions of Galectin-1
- (2010) Emma Salomonsson et al. BIOCHEMISTRY
- Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
- (2010) Kimberley A. Stannard et al. CANCER LETTERS
- Multimeric Lactoside “Click Clusters” as Tools to Investigate the Effect of Linker Length in Specific Interactions with Peanut Lectin, Galectin-1, and -3
- (2010) Sébastien G. Gouin et al. CHEMBIOCHEM
- Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis
- (2010) C-R Wang et al. GENE THERAPY
- Galectin multimerization and lattice formation are regulated by linker region structure
- (2010) L. A. Earl et al. GLYCOBIOLOGY
- Lung Cancer-Derived Galectin-1 Mediates Dendritic Cell Anergy through Inhibitor of DNA Binding 3/IL-10 Signaling Pathway
- (2010) P.-L. Kuo et al. JOURNAL OF IMMUNOLOGY
- Development of a Nascent Galectin-1 Chimeric Molecule for Studying the Role of Leukocyte Galectin-1 Ligands and Immune Disease Modulation
- (2010) F. Cedeno-Laurent et al. JOURNAL OF IMMUNOLOGY
- Synthesis and screening of a small glycomimetic library for inhibitory activity on medically relevant galactoside-specific lectins in assays of increasing biorelevance
- (2010) Sabine André et al. NEW JOURNAL OF CHEMISTRY
- Targeted Delivery of Protein Drugs by Nanocarriers
- (2010) Roberto Solaro et al. Materials
- Inhibiting Tumor Growth by Targeting Tumor Vasculature with Galectin-1 Antagonist Anginex Conjugated to the Cytotoxic Acylfulvene, 6-Hydroxylpropylacylfulvene
- (2009) Ruud P. M. Dings et al. BIOCONJUGATE CHEMISTRY
- Synthesis and Evaluation of New Thiodigalactoside-Based Chemical Probes to Label Galectin-3
- (2009) Monique van Scherpenzeel et al. CHEMBIOCHEM
- Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3
- (2009) Johan Tejler et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Synthesis of stable and selective inhibitors of human galectins-1 and -3
- (2008) Denis Giguère et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven
- (2008) Ruud P.M. Dings et al. CANCER LETTERS
- Calix[n]arene‐Based Glycoclusters: Bioactivity of Thiourea‐Linked Galactose/Lactose Moieties as Inhibitors of Binding of Medically Relevant Lectins to a Glycoprotein and Cell‐Surface Glycoconjugates and Selectivity among Human Adhesion/Growth‐Regulatory Galectins
- (2008) Sabine André et al. CHEMBIOCHEM
- Double Affinity Amplification of Galectin–Ligand Interactions through Arginine–Arene Interactions: Synthetic, Thermodynamic, and Computational Studies with Aromatic Diamido Thiodigalactosides
- (2008) Ian Cumpstey et al. CHEMISTRY-A EUROPEAN JOURNAL
- Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1
- (2008) Nozomu Nishi et al. GLYCOBIOLOGY
- Structural Features of Galectin-9 and Galectin-1 That Determine Distinct T Cell Death Pathways
- (2008) Shuguang Bi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow
- (2008) D. Cooper et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Arginine Binding Motifs: Design and Synthesis of Galactose-Derived Arginine Tweezers as Galectin-3 Inhibitors
- (2008) Christopher T. Öberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Galectin-Inhibitory Thiodigalactoside Ester Derivatives Have Antimigratory Effects in Cultured Lung and Prostate Cancer Cells
- (2008) Tamara Delaine et al. JOURNAL OF MEDICINAL CHEMISTRY
- Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease
- (2008) Sven Saussez et al. THYROID
- Roles of galectins in inflammatory bowel disease
- (2008) Akira Hokama et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption
- (2007) Simon Mercier et al. VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started